Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2016-09-20

Clinical Trial Update: Evaluation of the Effects of a Mixture of Amino Acids (Amixea) on Lean Body Mass and Muscle Strengh of Patients With Unresectable Advanced Non-small Cell Lung Cancer [NA]

View source ↗

Summary

A clinical trial evaluating Amixea, a mixture of amino acids, in lean body mass and muscle strength for patients with unresectable advanced non-small cell lung …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amixea (mixture of amino acids)

Snippet

Sponsor: Helsinn Healthcare SA | Conditions: Cancer Patients With Cachexia | NA | Status: WITHDRAWN